Free Trial

Guardant Health (GH) Stock Price, News & Analysis

Guardant Health logo
$43.38 -1.82 (-4.02%)
As of 01:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Guardant Health Stock (NASDAQ:GH)

Key Stats

Today's Range
$41.12
$46.25
50-Day Range
$37.05
$52.04
52-Week Range
$20.14
$53.42
Volume
4.78 million shs
Average Volume
2.28 million shs
Market Capitalization
$5.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$54.79
Consensus Rating
Buy

Company Overview

Guardant Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

GH MarketRank™: 

Guardant Health scored higher than 89% of companies evaluated by MarketBeat, and ranked 112th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Guardant Health has received a consensus rating of Buy. The company's average rating score is 3.05, and is based on 19 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Guardant Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Guardant Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Guardant Health are expected to grow in the coming year, from ($2.90) to ($2.84) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Guardant Health is -12.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Guardant Health is -12.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    8.05% of the float of Guardant Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Guardant Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Guardant Health has recently decreased by 6.40%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Guardant Health does not currently pay a dividend.

  • Dividend Growth

    Guardant Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.05% of the float of Guardant Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Guardant Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Guardant Health has recently decreased by 6.40%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Guardant Health has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.02 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 22 news articles for Guardant Health this week, compared to 9 articles on an average week.
  • Search Interest

    11 people have searched for GH on MarketBeat in the last 30 days. This is an increase of 57% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Guardant Health to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $17,082,238.00 in company stock.

  • Percentage Held by Insiders

    Only 6.10% of the stock of Guardant Health is held by insiders.

  • Percentage Held by Institutions

    92.60% of the stock of Guardant Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Guardant Health's insider trading history.
Receive GH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter.

GH Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Guardant Health (GH) Q2 Revenue Up 31%
See More Headlines

GH Stock Analysis - Frequently Asked Questions

Guardant Health's stock was trading at $30.55 at the start of the year. Since then, GH shares have increased by 41.9% and is now trading at $43.3470.

Guardant Health, Inc. (NASDAQ:GH) announced its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.49) EPS for the quarter, beating the consensus estimate of ($0.57) by $0.08. The company's revenue for the quarter was up 20.8% on a year-over-year basis.
Read the conference call transcript
.

Guardant Health (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers.

Top institutional shareholders of Guardant Health include ARK Investment Management LLC (2.28%), Aberdeen Group plc (0.14%), Sicart Associates LLC (0.13%) and TD Asset Management Inc (0.13%). Insiders that own company stock include Helmy Eltoukhy, Amirali Talasaz, Amelia Merrill, Myrtle S Potter, Kumud Kalia, Meghan V Joyce, Ian T Clark and Musa Tariq.
View institutional ownership trends
.

Shares of GH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardant Health investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Salesforce (CRM), Advanced Micro Devices (AMD), CrowdStrike (CRWD) and Adobe (ADBE).

Company Calendar

Last Earnings
4/30/2025
Today
7/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:GH
CIK
1576280
Employees
2,021
Year Founded
N/A

Price Target and Rating

High Price Target
$70.00
Low Price Target
$35.00
Potential Upside/Downside
+21.0%
Consensus Rating
Buy
Rating Score (0-4)
3.05
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.39)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$436.37 million
Net Margins
-53.82%
Pretax Margin
-53.67%
Return on Equity
N/A
Return on Assets
-26.77%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.11
Quick Ratio
3.76

Sales & Book Value

Annual Sales
$739.02 million
Price / Sales
7.58
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.13) per share
Price / Book
-39.99

Miscellaneous

Outstanding Shares
123,890,000
Free Float
116,331,000
Market Cap
$5.60 billion
Optionable
Not Optionable
Beta
1.44
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GH) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners